Announcement of TTY Biopharm's unaudited income information in March 2022
2022.4.13
Provided by: TTY BIOPHARM COMPANY LIMITED
| SEQ_NO | 1 | Date of announcement | 2022/04/13 | Time of announcement | 13:39:39 |
| Subject | Announcement of TTY Biopharm's unaudited income information in March 2022 | ||||
| Date of events | 2022/04/13 | To which item it meets | paragraph 53 | ||
| Statement | 1.Date of occurrence of the event:2022/04/13 2.Company name:TTY Biopharm Co., Ltd. 3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office 4.Reciprocal shareholding ratios:N/A 5.Cause of occurrence:TTY Biopharm posted a consolidated net sales of $367,243 thousands (expressed in NT dollars; unaudited), a consolidated operating profit of $81,126 thousands, and a consolidated income before tax of $109,405 thousands in March 2022; net income attributed to stockholders of the company was $88,323 thousands; EPS is $0.36. Year-to-date consolidated net sales was $1,037,117 thousands (in NT dollars; unaudited), a consolidated operating profit was $246,564 thousands and consolidated income before tax was $287,248 thousands until March 2022; year-to-date net income attributed to stockholders of the company was $227,508 thousands; EPS is $0.91. 6.Countermeasures:N/A 7.Any other matters that need to be specified: The numbers above are unaudited. In term of the final net sales and profits, quarterly financial reports audited by independent accountants will prevail. |
||||